DCP Capital is an international private equity firm established in 2017 and headquartered in Beijing, China. The firm specializes in identifying investment opportunities across various sectors, including healthcare devices, semiconductors, commercial services, agriculture, and manufacturing, primarily within Mainland China, Hong Kong, Macau, and Taiwan. The DCP team boasts significant experience, having previously led private equity operations at notable institutions, and maintains a strong track record through diverse economic conditions. DCP Capital focuses on building long-term value in its portfolio companies while leveraging its extensive industry knowledge and network.
Managing Director and Member of the Investment Committee
David H. Liu
Co-Founder, Executive Chairman and member of the Investment Committee
Wayne Wang
Partner / Managing Director
Julian Wolhardt
Co-Founder, CEO and member of the Investment Committee
Howard Zhang
Managing Director
18 past transactions
Sun Art Retail Group
Acquisition in 2025
Sun Art Retail Group Limited is a prominent retail company in China that specializes in hypermarkets and e-commerce platforms. Operating under the well-known brands RT-Mart and Auchan, the company has established a substantial presence with 486 outlets across 232 cities and a total gross floor area of approximately 13 million square meters as of December 2019. Founded in 1998 and headquartered in Wan Chai, Hong Kong, Sun Art focuses on enhancing its hypermarket complexes and exploring multi-format and omni-channel retail strategies. The company's commitment to digital transformation aims to position it as a leader in the evolving retail landscape. Sun Art Retail Group is a subsidiary of Taobao China Holding Limited.
Jamieson Wellness
Private Equity Round in 2023
Jamieson Wellness specializes in the production of high-quality dietary supplements, offering a diverse portfolio of 225 products, including over 50 proprietary formulations designed to enhance vitality and promote overall wellness for families. The company sources its ingredients from a global network of natural suppliers and conducts comprehensive research, testing, manufacturing, and distribution at its advanced facilities in Windsor, Ontario. Each product adheres to the 360 Pure promise, which involves a minimum of 360 quality-control tests to ensure potency and purity. Additionally, Jamieson Wellness is committed to environmental stewardship and animal welfare through its Jamieson Cares initiative, which supports reforestation and animal protection projects both in Canada and internationally.
Jamieson Wellness
Post in 2023
Jamieson Wellness specializes in the production of high-quality dietary supplements, offering a diverse portfolio of 225 products, including over 50 proprietary formulations designed to enhance vitality and promote overall wellness for families. The company sources its ingredients from a global network of natural suppliers and conducts comprehensive research, testing, manufacturing, and distribution at its advanced facilities in Windsor, Ontario. Each product adheres to the 360 Pure promise, which involves a minimum of 360 quality-control tests to ensure potency and purity. Additionally, Jamieson Wellness is committed to environmental stewardship and animal welfare through its Jamieson Cares initiative, which supports reforestation and animal protection projects both in Canada and internationally.
Simple Love
Series C in 2022
Simple Love is a natural yoghurt brand.
51job
Acquisition in 2022
51job.com is a leading recruitment platform in China, boasting over 72 million registered members and the largest resume database in the country. Established in 1998, it offers a comprehensive range of services including recruitment solutions, training and assessment, HR outsourcing, and consulting. With a robust infrastructure supported by a large team of experienced professionals, 51job.com effectively integrates traditional and digital media to deliver innovative recruitment strategies. The platform features an average of 2.7 million job postings and facilitates around 38 million applications to employers each week. Recognized for its market leadership, 51job.com has consistently ranked first in market share and has received accolades for its influence in the HR industry. The company operates 25 offices across Mainland China, serving numerous domestic and multinational clients.
Adopt A Cow
Series B in 2021
Adopt A Cow is a fast-growing, direct-to-consumer dairy company in China that integrates digital solutions into its core operations.
Datong
Private Equity Round in 2021
Datong Insurance is a professional third-party financial insurance service organization. Datong’s subsidiaries include Datong Insurance Sales Service Co., Ltd., Beijing Datong Insurance Brokers Co., Ltd., among which Datong Insurance Sales Service Co., Ltd. is approved by the China Insurance Regulatory Commission. The first national insurance professional sales and service organization approved to be established. At present, the Datong service network has covered more than 20 provinces and municipalities across the country.
Valgen Medtech
Series B in 2021
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.
Adopt A Cow
Private Equity Round in 2021
Adopt A Cow is a fast-growing, direct-to-consumer dairy company in China that integrates digital solutions into its core operations.
Simple Love
Series B in 2021
Simple Love is a natural yoghurt brand.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng, founded in 2009 and based in Changsha, China, operates a network of convenience stores that focus on community shopping. The company offers a variety of fresh products, including vegetables, fruits, meat, poultry, seafood, and general merchandise. It employs a novel retail model that combines online ordering with offline pick-up, catering to the daily needs of household consumers. In addition to its retail operations, Furong Xingsheng also specializes in B2B logistics and distribution services, enhancing its efficiency in serving the local market.
Fenbi
Series A in 2021
Fenbi Wang provides vocational education examination services.
Yuanfudao
Series G in 2020
Yuanfudao, founded in 2012, is the largest online live course platform in China, catering to primary and secondary school students. With over 1 million paying users, it provides a comprehensive curriculum that includes subjects such as English, Mathematical Olympiad, and various all-subject courses for secondary education. The platform features live online tutoring conducted by nationally recognized teachers, allowing students to receive quality education from home. By utilizing big data analysis, Yuanfudao enables students to identify their learning weaknesses and engage in targeted learning, thus enhancing their educational outcomes. The combination of its extensive course offerings and a large pool of qualified educators benefits hundreds of thousands of students across the country.
Broncus Medical
Series C in 2020
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.
Tonghua Dongbao Pharmaceutical
Post in 2020
Tonghua Dongbao Pharmaceutical Co., Ltd. is a China-based company that specializes in the research, development, manufacturing, and sale of pharmaceutical products primarily aimed at treating diabetes and cardiovascular diseases. The company's product range includes various insulin analogues such as insulin glargine and insulin aspart, along with antidiabetic agents and oral hypoglycemic medications. Additionally, it offers medical devices like blood glucose meters and insulin pens. The firm is also engaged in the development of several clinical-stage therapies, including recombinant human interferon injections for hepatitis treatment and granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. Beyond its pharmaceutical endeavors, Tonghua Dongbao produces building materials, including plastic windows. Founded in 1985, the company is headquartered in Tonghua, China.
Far East Horizon
Post in 2019
Far East Horizon is a financial services organization that specializes in providing integrated operational solutions across various sectors, including healthcare, infrastructure, transportation, and electronics. The company focuses on offering tailored services such as financial leasing, investment, trade brokering, management consulting, and construction services. Its business is divided into two main segments: the financial, lease, and advisory segment, which generates the majority of its revenue through services like direct finance leasing and entrusted loans; and the industrial operation and management segment, which involves trade activities related to medical equipment and other industries. By aligning financial resources with industry needs, Far East Horizon aims to create a competitive advantage through the joint development of finance and industry.
Venus Medtech
Private Equity Round in 2018
Venus Medtech (Hangzhou) Inc. is a medical device company that specializes in the development and sale of transcatheter heart valve solutions, primarily targeting structural heart diseases. Founded in 2009 and headquartered in Hangzhou, China, the company offers a range of products, including the VenusA-Valve, a transcatheter aortic heart valve replacement designed to treat severe aortic stenosis, and the VenusP-Valve, which addresses dysfunction in the right ventricular outflow tract. Venus Medtech also markets advanced devices such as the V8/TAV8 balloon aortic valvuloplasty catheter systems and the TriGUARD3 cerebral embolic protection device, aimed at minimizing cerebral damage during heart procedures. Additionally, the company is working on new product candidates, including VenusA-Plus and VenusA-Pilot, and is expanding its portfolio to include transcatheter mitral and tricuspid valve replacements. The company is recognized for its contributions to the field and is positioned to meet the increasing clinical demands for innovative heart valve therapies in China and beyond.
Guorui New Materials
Guorui New Materials produces special graphite and provides supporting products for high - temperature gas cooled reactor nuclear fuels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.